In silco modelling to predict the drug plasma concentrations of dextromethophan in populations with pharmacogenomic variations.
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: SARFRAZ, Muhammad (University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, alberta, Canada)
- Co-author(s): L, Raimar (University of Alberta, Edmonton, alberta, Canada)
Background: Physiological based pharmacokinetic in silico modeling has become an integral tool in formulation development for Quality by Design (QbD) approach. Various pharmaceutical Industries used it as a tool for screening of chemical entities at drug development or formulation stage.
Aims: The purpose of this study was to investigate how.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.